CDC, States Update Number of Hospitalized EVALI Cases and EVALI Deaths

Media Statement

For Immediate Release: Tuesday, February 25, 2020
Contact: Media Relations
(404) 639-3286

CDC today announced the updated number of hospitalized e-cigarette, or vaping, product use associated lung injury (EVALI) cases* and EVALI deaths.

As of Feb. 18, 2020, 2,807 cases of hospitalized EVALI or deaths were reported by all 50 states, the District of Columbia, and 2 U.S. territories (Puerto Rico, and the U.S. Virgin Islands).

EVALI Deaths

As of Feb. 18, 2020, 68 deaths have been confirmed in 29 states and the District of Columbia:
- Alabama, California (4), Connecticut, Delaware, District of Columbia, Florida (2), Georgia (6), Illinois (5), Indiana (6), Kansas (2), Kentucky, Louisiana (2), Massachusetts (5), Michigan (3), Minnesota (3), Mississippi, Missouri (2), Montana, Nebraska, New Jersey, New York (4), Oregon (2), Pennsylvania, Rhode Island, South Carolina, Tennessee (2), Texas (4), Utah, Virginia, and Washington (2).

Due to continued declines in new EVALI cases since September 2019, and the identification of vitamin E acetate as a primary cause of EVALI, today’s release is the final biweekly CDC update on the number of hospitalized EVALI cases and deaths nationally. CDC will continue to provide assistance to states, as needed, related to EVALI and will provide future updates as needed at: www.cdc.gov/lunginjury.

*As of Dec. 3, 2019, CDC only reports hospitalized EVALI cases. CDC reports EVALI deaths, regardless of hospitalization status.